Dr. Robert A. Nagourney, MD
Metastatic or Recurrent Cancer Patients Can’t Afford to Guess
Cancer patients deserve better. Every patient is unique. Their treatment should be as well.
top of page
Cancer Blog
- Dr. Robert Nagourney -
Search
Dr. Robert A. Nagourney, MD
- Apr 2
- 3 min
A Ray of Hope in the Fight Against Stage 4 Colon Cancer
Daniel Werner, a dedicated nurse and a loving fiancé and father, faced the grim reality of a stage 4 colon cancer diagnosis in December 2021
Dr. Robert A. Nagourney, MD
- Mar 12
- 2 min
What’s a Pancreatic Cancer Doctor to do? More Importantly: What are Their Patients to do?
Screening for Pancreatic cancer, even in the highest-risk individuals found not cost effective.
Dr. Robert A. Nagourney, MD
- Mar 4
- 2 min
Breakthrough in Pancreatic Cancer: New Blood Test for Early Detection, Could Offer Improved Therapy
Blood test results offer a “cancer signature” that distinguishes patients with pancreatic cancer from normal individuals.
Dr. Robert A. Nagourney, MD
- Feb 9
- 2 min
Functional Profiling for Cancer is Scientifically Validated by Peer-Review
One of the critical advantages of Functional Profiling over traditional genomic testing is its focus on the actual response of cancer cells.
Dr. Robert A. Nagourney, MD
- Jan 31
- 3 min
What Have Medical Oncologists Lost? Empathy!
Cancer patients approach their diagnosis with a sense of terror. One day they are fine and feeling well and the next, a terminal diagnosis.
Dr. Robert A. Nagourney, MD
- Jan 23
- 3 min
For Advanced Cancer Patients: Whose Life is It Anyway?
Rising corporate influence and focus on reimbursement in medicine now discourage doctors from straying from strict treatment guidelines.
Dr. Robert A. Nagourney, MD
- Jan 15
- 2 min
Personalized Medicine Is More Than a Marketing Buzzword at Nagourney Cancer Institute
Cancer therapy can be really expensive. But here's the kicker, Functional Profiling costs way less than receiving the incorrect treatment.
Dr. Robert A. Nagourney, MD
- Dec 7, 2023
- 2 min
The Cancer Clinical Trial Process is in Need of Revision
Patients with advanced malignancies often seek the expertise of physicians at major institutions.
Dr. Robert A. Nagourney, MD
- Oct 30, 2023
- 3 min
Hitting Cancer True and Straight: the Role of Tissue Analysis
Although she showed some response, her disease persisted and she was being considered for surgery to remove the residual tumor...
Dr. Robert A. Nagourney, MD
- Sep 26, 2023
- 2 min
Your Cancer Cure May Already Exist
Personalized treatment means more cured patients. More people survive cancer when our Functional Profiling system is used before treatment.
Dr. Robert A. Nagourney, MD
- Aug 14, 2023
- 3 min
“New” Immune Therapy Active in Late-Stage Cancer Patients
Here in 2023, we
suddenly discover that TIL cells are highly active against cancer, but it was Steven Rosenberg who first described it.
Dr. Robert A. Nagourney, MD
- Jul 24, 2023
- 2 min
Stage 4 Cancer Patient Survivals: The Data Is In and It’s Not Good
There has been talk of improved survival in cancer, most progress has reflected screening, early diagnosis, improved staging, and support.
Dr. Robert A. Nagourney, MD
- Jun 26, 2023
- 3 min
Challenging Paradigms: The Management of Rectal Cancer
One noteworthy case was a 78-year-old patient successfully treated without surgery.
Dr. Robert A. Nagourney, MD
- Jun 2, 2023
- 2 min
Breakthrough for Young Patients with a Rare Form of Liver Cancer
Extremely rare liver cancer that mostly affects people in their twenties associated with a gene rearrangement, mostly lethal, until now.
Dr. Robert A. Nagourney, MD
- May 19, 2023
- 3 min
For Medical Oncology, Déjà Vu All Over Again
Patients are being encouraged to contact the researchers to get biopsies and help take charge of their disease.
Dr. Robert A. Nagourney, MD
- May 15, 2023
- 4 min
Nagourney Cancer Institute: 20-year Experience in 10,000 Patients
At the 2023 American Association for Cancer Research meeting in Orlando, we reported results of ex vivo analysis of programmed cell death.
Dr. Robert A. Nagourney, MD
- Mar 27, 2023
- 2 min
Benefits of Combining Functional Profiling with Nagourney Cancer Institute's 11,000 Patient Studies
Combining Functional Profiling with Nagourney Cancer Institute's 11,000 patient studies provides personalized cancer treatment plans.
Dr. Robert A. Nagourney, MD
- Feb 15, 2023
- 2 min
Functional Profiling vs. Functional Medicine: What’s the Difference?
We take a different approach to the treatment of cancer – based on profiling how our patients’ cancerous cells will respond to treatment.
Dr. Robert A. Nagourney, MD
- Jan 30, 2023
- 3 min
Treatment for Stage 4 Pancreatic Cancer May Be at Hand
After the recommended treatment, FOLFIRINOX, using his tissue we suggested new classes of drugs that target P53 and MEK/ERK.
Nagourney Cancer Institute is managed by Rational Therapeutics, LLC.
EVA-PCD, Target Rx, and Translational Rx are registered trademarks of Rational Therapeutics.
Nagourney Cancer Institute. 750 E. 29th Street, Long Beach, CA 90806 (800) 542-4357 All rights reserved.
bottom of page